These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

439 related items for PubMed ID: 26215403

  • 1. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Wilson AJ, Saskowski J, Barham W, Yull F, Khabele D.
    J Ovarian Res; 2015 Jul 28; 8():46. PubMed ID: 26215403
    [Abstract] [Full Text] [Related]

  • 2. Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancer.
    Wilson AJ, Saskowski J, Barham W, Khabele D, Yull F.
    Mol Cancer; 2015 Nov 09; 14():192. PubMed ID: 26552746
    [Abstract] [Full Text] [Related]

  • 3. Tracking NF-κB activity in tumor cells during ovarian cancer progression in a syngeneic mouse model.
    Wilson AJ, Barham W, Saskowski J, Tikhomirov O, Chen L, Lee HJ, Yull F, Khabele D.
    J Ovarian Res; 2013 Sep 10; 6(1):63. PubMed ID: 24020521
    [Abstract] [Full Text] [Related]

  • 4. The Effect of Thymoquinone on Apoptosis of SK-OV-3 Ovarian Cancer Cell by Regulation of Bcl-2 and Bax.
    Liu X, Dong J, Cai W, Pan Y, Li R, Li B.
    Int J Gynecol Cancer; 2017 Oct 10; 27(8):1596-1601. PubMed ID: 28692636
    [Abstract] [Full Text] [Related]

  • 5. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo.
    Jafri SH, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H.
    J Exp Clin Cancer Res; 2010 Jul 01; 29(1):87. PubMed ID: 20594324
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Thymoquinone overcomes chemoresistance and enhances the anticancer effects of bortezomib through abrogation of NF-κB regulated gene products in multiple myeloma xenograft mouse model.
    Siveen KS, Mustafa N, Li F, Kannaiyan R, Ahn KS, Kumar AP, Chng WJ, Sethi G.
    Oncotarget; 2014 Feb 15; 5(3):634-48. PubMed ID: 24504138
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
    Şakalar Ç, İzgi K, İskender B, Sezen S, Aksu H, Çakır M, Kurt B, Turan A, Canatan H.
    Tumour Biol; 2016 Apr 15; 37(4):4467-77. PubMed ID: 26500095
    [Abstract] [Full Text] [Related]

  • 12. Thymoquinone attenuates proinflammatory responses in lipopolysaccharide-activated mast cells by modulating NF-kappaB nuclear transactivation.
    El Gazzar MA, El Mezayen R, Nicolls MR, Dreskin SC.
    Biochim Biophys Acta; 2007 Apr 15; 1770(4):556-64. PubMed ID: 17292554
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Romidepsin (FK228) combined with cisplatin stimulates DNA damage-induced cell death in ovarian cancer.
    Wilson AJ, Lalani AS, Wass E, Saskowski J, Khabele D.
    Gynecol Oncol; 2012 Dec 15; 127(3):579-86. PubMed ID: 23010348
    [Abstract] [Full Text] [Related]

  • 16. Salinomycin inhibits Akt/NF-κB and induces apoptosis in cisplatin resistant ovarian cancer cells.
    Parajuli B, Lee HG, Kwon SH, Cha SD, Shin SJ, Lee GH, Bae I, Cho CH.
    Cancer Epidemiol; 2013 Aug 15; 37(4):512-7. PubMed ID: 23545383
    [Abstract] [Full Text] [Related]

  • 17. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S, Sperandio O, Raza H, Arafat K, Al-Salam S, Al Sultan MA, Al Safi M, Takahashi T, Adem A.
    Fundam Clin Pharmacol; 2013 Oct 15; 27(5):557-69. PubMed ID: 22788741
    [Abstract] [Full Text] [Related]

  • 18. Combination of ciglitazone, a peroxisome proliferator-activated receptor gamma ligand, and cisplatin enhances the inhibition of growth of human ovarian cancers.
    Yokoyama Y, Xin B, Shigeto T, Mizunuma H.
    J Cancer Res Clin Oncol; 2011 Aug 15; 137(8):1219-28. PubMed ID: 21681689
    [Abstract] [Full Text] [Related]

  • 19. Antitumor and anti-angiogenesis effects of thymoquinone on osteosarcoma through the NF-κB pathway.
    Peng L, Liu A, Shen Y, Xu HZ, Yang SZ, Ying XZ, Liao W, Liu HX, Lin ZQ, Chen QY, Cheng SW, Shen WD.
    Oncol Rep; 2013 Feb 15; 29(2):571-8. PubMed ID: 23232982
    [Abstract] [Full Text] [Related]

  • 20. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N, Zhao X, Xiang Y, Ye S, Huang J, Hu W, Lv L, Zeng C.
    Int J Cardiol; 2016 Oct 15; 221():587-96. PubMed ID: 27420584
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.